20/20 Biolabs, Inc.
AIDX
$1.46
$0.096.33%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.31M | -825.50K | -802.80K | -802.80K | -1.25M |
| Total Depreciation and Amortization | 20.10K | 21.10K | 22.30K | 22.30K | 32.60K |
| Total Amortization of Deferred Charges | 97.90K | 17.20K | -- | -- | 0.00 |
| Total Other Non-Cash Items | 398.00K | 127.80K | 127.80K | 127.80K | 668.30K |
| Change in Net Operating Assets | 280.00K | 273.80K | 141.50K | 141.50K | 11.70K |
| Cash from Operations | -511.70K | -385.70K | -511.20K | -511.20K | -536.50K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 411.90K | 506.60K | 35.00K | 35.00K | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.80K | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 0.00 | 0.00 | 96.20K | 96.20K | 110.00K |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -23.90K | -- | -- | -- | -- |
| Cash from Financing | 392.80K | 506.60K | 131.20K | 131.20K | 110.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -118.90K | 120.90K | -380.00K | -380.00K | -426.40K |